Kolchinsky Peter - Net Worth and Insider Trading
Kolchinsky Peter Net Worth
The estimated net worth of Kolchinsky Peter is at least $41 Million dollars as of 2025-07-10. Kolchinsky Peter is the 2305 Beneficiary of a trust of Canbridge Pharmaceuticals Inc and owns about 60,235,590 shares of Canbridge Pharmaceuticals Inc (HKSE:01228) stock worth over $41 Million. Details can be seen in Kolchinsky Peter's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kolchinsky Peter has not made any transactions after 2021-12-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kolchinsky Peter
Kolchinsky Peter Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kolchinsky Peter owns 1 companies in total, including Canbridge Pharmaceuticals Inc (HKSE:01228) .
Click here to see the complete history of Kolchinsky Peter’s form 4 insider trades.
Insider Ownership Summary of Kolchinsky Peter
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01228 | Canbridge Pharmaceuticals Inc | 2021-12-10 | 2305 Beneficiary of a trust |
Kolchinsky Peter Latest Holdings Summary
Kolchinsky Peter currently owns a total of 1 stock. Kolchinsky Peter owns 60,235,590 shares of Canbridge Pharmaceuticals Inc (HKSE:01228) as of December 10, 2021, with a value of $41 Million.
Latest Holdings of Kolchinsky Peter
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01228 | Canbridge Pharmaceuticals Inc | 2021-12-10 | 60,235,590 | 0.68 | 40,960,201 |
Holding Weightings of Kolchinsky Peter
Kolchinsky Peter Form 4 Trading Tracker
According to the SEC Form 4 filings, Kolchinsky Peter has made a total of 1 transactions in Canbridge Pharmaceuticals Inc (HKSE:01228) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Canbridge Pharmaceuticals Inc is the acquisition of 4,500,000 shares on December 10, 2021, which cost Kolchinsky Peter around $40 Million.
Insider Trading History of Kolchinsky Peter
- 1
Kolchinsky Peter Trading Performance
GuruFocus tracks the stock performance after each of Kolchinsky Peter's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kolchinsky Peter is -33.26%. GuruFocus also compares Kolchinsky Peter's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kolchinsky Peter within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kolchinsky Peter's insider trading performs compared to the benchmark.
Performance of Kolchinsky Peter
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.4 | | | | | |
| Relative Return to S&P 500(%) | -5.51 | | | | | |
Kolchinsky Peter Ownership Network
Ownership Network List of Kolchinsky Peter
Ownership Network Relation of Kolchinsky Peter
Kolchinsky Peter Owned Company Details
What does Canbridge Pharmaceuticals Inc do?
Who are the key executives at Canbridge Pharmaceuticals Inc?
Kolchinsky Peter is the 2305 Beneficiary of a trust of Canbridge Pharmaceuticals Inc. Other key executives at Canbridge Pharmaceuticals Inc include 2102 Investment manager Athos Capital Limited , 2201 Interest of corporation controlled by you Moskey Matthew Love , and 2201 Interest of corporation controlled by you Schulte-Hillen Friedrich Bela .
Canbridge Pharmaceuticals Inc (HKSE:01228) Insider Trades Summary
Over the past 18 months, Kolchinsky Peter made no insider transaction in Canbridge Pharmaceuticals Inc (HKSE:01228). Other recent insider transactions involving Canbridge Pharmaceuticals Inc (HKSE:01228) include a net sale of 0 shares made by Xue James Qun , a net purchase of 19,516,700 shares made by JPMorgan Chase & Co. , and a net sale of 13,873,000 shares made by Moskey Matthew Love .
In summary, during the past 3 months, insiders sold 52,593,000 shares of Canbridge Pharmaceuticals Inc (HKSE:01228) in total and bought 0 shares, with a net sale of 52,593,000 shares. During the past 18 months, 54,946,260 shares of Canbridge Pharmaceuticals Inc (HKSE:01228) were sold and 19,516,700 shares were bought by its insiders, resulting in a net sale of 35,429,560 shares.
Canbridge Pharmaceuticals Inc (HKSE:01228)'s detailed insider trading history can be found in Insider Trading Tracker table.
Canbridge Pharmaceuticals Inc Insider Transactions
Kolchinsky Peter Mailing Address
Above is the net worth, insider trading, and ownership report for Kolchinsky Peter. Currently GuruFocus does not have mailing address information for Kolchinsky Peter.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
